Acute Porphyria Drugs

Monograph

R03AC13 - Formoterol
Propably not porphyrinogenic
PNP

Rationale
Probably insignificant systemic exposure.
Chemical description
Adrenergic selective beta-2-stimulator with long durationof effect, administered as inhalation powder (12 µg/dose) in bronchial asthma. About 90% of the dose may be swallowed and absorbed. Plasma cancentrations are below the detection limit. Eliminated after direct glucuronidation and 0-demetylation followed by glucuronidation.
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes R03A / R03AC or go back.
References
Tradenames

Atimos · Formoterol · Oxis Foradil · Formagal · Formoair · Formoterol · Oxis Broncoral · Foradil · Formatris · Formoterol · Oxis Atimos · Chemoterol · Formoterol · Inhafort Atimos · Foradil · Formoterolo · Forotan · Fortasint · Kurovent · Levovent · Liferol · Oxis Atimos Foradil · Oxis Atimos Modulite · Foradil · Formoterol Easyhaler · Oxis 12 · Oxis 6 Atimos · Chemoterol · Foradil · Formo · Formochem · Formoterol · Formotifi · Oxis Oxis Atimos · Foradil · Foramed · Forastmin · Formoterol · Oxis · Oxodil · Zafiron Foradil-p · Formagal · Formoterol · Oxis Oxis Formaxa · Formoterol · Oxis Aircosona · Atimos · Fomeda · Foradil · Fortulin · Galiron Atimos · Fomeda · Foradil · Oxis Aircosona · Atimos · Fomeda · Foradil · Fortulin · Galiron · Oxis Oxis Atimos · Fortulin · Oxis
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙